Handok launches Tracleer in pulmonary arterial hypertension
In March of this year, the Korea Food and Drug Administration granted formal approval of Tracleer for the treatment of all forms of pulmonary arterial hypertension ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
